Poland
· Delayed Price · Currency is PLN InventionMed Statistics
Total Valuation
InventionMed has a market cap or net worth of PLN 37.21 million. The enterprise value is 39.70 million.
| Market Cap | 37.21M |
| Enterprise Value | 39.70M |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
InventionMed has 202.79 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 202.79M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.61% |
| Owned by Institutions (%) | n/a |
| Float | 113.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 134.04 |
| PB Ratio | 19.31 |
| P/TBV Ratio | 20.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.92 |
| EV / Sales | 142.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02, with a Debt / Equity ratio of 1.29.
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | 1.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.61 |
Financial Efficiency
Return on equity (ROE) is -101.89% and return on invested capital (ROIC) is -22.70%.
| Return on Equity (ROE) | -101.89% |
| Return on Assets (ROA) | -3.81% |
| Return on Invested Capital (ROIC) | -22.70% |
| Return on Capital Employed (ROCE) | -10.55% |
| Revenue Per Employee | 39,680 |
| Profits Per Employee | -571,882 |
| Employee Count | 7 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.50% in the last 52 weeks. The beta is 0.52, so InventionMed's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -21.50% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 0.20 |
| Relative Strength Index (RSI) | 51.17 |
| Average Volume (20 Days) | 128,453 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, InventionMed had revenue of PLN 277,760 and -4.00 million in losses. Loss per share was -0.02.
| Revenue | 277,760 |
| Gross Profit | 97,583 |
| Operating Income | -2.47M |
| Pretax Income | -4.00M |
| Net Income | -4.00M |
| EBITDA | -1.62M |
| EBIT | -2.47M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 6,095 in cash and 2.49 million in debt, giving a net cash position of -2.49 million or -0.01 per share.
| Cash & Cash Equivalents | 6,095 |
| Total Debt | 2.49M |
| Net Cash | -2.49M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 1.93M |
| Book Value Per Share | 0.01 |
| Working Capital | -14.41M |
Cash Flow
| Operating Cash Flow | 695,573 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 35.13% |
| Operating Margin | -889.33% |
| Pretax Margin | -1,441.23% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InventionMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -10.76% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 6, 2022. It was a forward split with a ratio of 4.
| Last Split Date | Sep 6, 2022 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
InventionMed has an Altman Z-Score of -1.11. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.11 |
| Piotroski F-Score | n/a |